Press Releases
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA® (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting
Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC)...